CivaTech Oncology:Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet
Brief description of study
This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical structures, such as the heart wall, while giving a therapeutic dose to diseased tissue, such as at a surgical margin
Clinical Study Identifier: s17-01418
ClinicalTrials.gov Identifier: NCT03290534
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
